The peptide is often sold through unregulated channels as a 'research chemical' or unauthorised medicine, raising significant concerns about purity, dosage accuracy, and contamination
Banerjee et al., 2024) or neurosurgical procedures (Panteleienko et al., 2024), respectively
I dont agree with people who harp on about its not regulated
It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 2324, 2026
GHK-Cu topical: 1 %3 % for skin, 0.5 % for scalp AHK-Cu topical: 0.05 %0.1 % is standard in most hair serums - note this is much lower than GHK-Cu percentages Injectable AHK-Cu: less well characterised
To maintain results, follow-up treatments are typically spaced out by 9 to 12 months